Characterization of pancreatic ductal cells in human islet preparations

Laboratory Investigation

Volumn 88, Issue 11, 2008, Pages 1167-1177

  Ichii, Hirohito ^a,b   Miki, Atsushi ^a   Yamamoto, Toshiyuki ^a   Molano, Ruth D ^a   Barker, Scott ^a   Mita, Atsuyoshi ^a   Rodriguez Diaz, Rayner ^a   Klein, Dagmar ^a   Pastori, Ricardo ^a   Alejandro, Rodolfo ^a   Inverardi, Luca ^a   Pileggi, Antonello ^a   Ricordi, Camillo ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Florida   (United States)

Author keywords

CA19 9; Cytokines; Islet transplantation; Laser scanning cytometer; Pancreatic ductal cells; VEGF

Indexed keywords

7 AMINODACTINOMYCIN; CA 19-9 ANTIGEN; DYE; TETRAMETHYLRHODAMINE ETHYL ESTER; THROMBOPLASTIN; VASCULOTROPIN;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; LASER SCANNING CYTOMETRY; MOUSE; NONHUMAN; PANCREAS DUCT; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; CA-19-9 ANTIGEN; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; KERATIN-19; LASER SCANNING CYTOMETRY; MICE; MICE, NUDE; PANCREATIC DUCTS; PHENOTYPE;

EID: 54949110135     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2008.87     Document Type: Article

References (48)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-238.
2. Markmann JF, Deng S, Huang X, et al. Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 2003;237:741-749.
3. Hering BJ, Kandaswamy R, Harmon JV, et al. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant 2004;4:390-401.
4. Froud T, Ricordi C, Baidal DA, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005;5:2037-2046.
5. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006;355:1318-1330.
6. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005;54:2060-2069.
7. Zhang N, Su D, Qu S, et al. Sirolimus is associated with reduced islet engraftment and impaired beta-cell function. Diabetes 2006;55:2429-2436.
8. Bussiere CT, Lakey JR, Shapiro AM, et al. The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells. Diabetologia 2006;49:2341-2349.
9. Holland AM, Gonez LJ, Harrison LC, et al. Progenitor cells in the adult pancreas. Diabetes Metab Res Rev 2004;20:13-27.
10. Yatoh S, Dodge R, Akashi T, et al. Differentiation of affinity-purified human pancreatic duct cells to beta-cells. Diabetes 2007;56:1802-1809.
11. Ramiya VK, Maraist M, Arfors KE, et al. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med 2000;6:278-282.
12. Bonner-Weir S, Taneja M, Weir GC, et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 2000;97:7999-8004.
13. Gao R, Ustinov J, Pulkkinen MA, et al. Characterization of endocrine progenitor cells and critical factors for their differentiation in human adult pancreatic cell culture. Diabetes 2003;52:2007-2015.
14. Ilieva A, Yuan S, Wang RN, et al. Pancreatic islet cell survival following islet isolation: the role of cellular interactions in the pancreas. J Endocrinol 1999;161:357-364.
15. Robitaille R, Dusseault J, Henley N, et al. Insulin-like growth factor II allows prolonged blood glucose normalization with a reduced islet cell mass transplantation. Endocrinology 2003;144:3037-3045.
16. Street CN, Lakey JR, Shapiro AM, et al. Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. Diabetes 2004;53:3107-3114.
17. Movahedi B, Gysemans C, Jacobs-Tulleneers-Thevissen D, et al. Pancreatic duct cells in human islet-cell preparations are a source of angiogenic cytokines IL-8 and VEGF. Diabetes 2008;57:2128-2136.
18. Pavlovic D, Chen MC, Bouwens L, et al. Contribution of ductal cells to cytokine responses by human pancreatic islets. Diabetes 1999;48:29-33.
19. Beuneu C, Vosters O, Movahedi B, et al. Human pancreatic duct cells exert tissue factor-dependent procoagulant activity: relevance to islet transplantation. Diabetes 2004;53:1407-1411.
20. Latif ZA, Noel J, Alejandro R. A simple method of staining fresh and cultured islets. Transplantation 1988;45:827-830.
21. Kuroda Y, Kawamura T, Suzuki Y, et al. A new, simple method for cold storage of the pancreas using perfluorochemical. Transplantation 1988;46:457-460.
22. Ricordi C, Lacy PE, Finke EH, et al. Automated method for isolation of human pancreatic islets. Diabetes 1988;37:413-420.
23. Ichii H, Pileggi A, Molano RD, et al. Rescue purification maximizes the use of human islet preparations for transplantation. Am J Transplant 2005;5:21-30.
24. Ichii H, Inverardi L, Pileggi A, et al. A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant 2005;5:1635-1645.
25. Ichii H, Wang X, Messinger S, et al. Improved human islet isolation using nicotinamide. Am J Transplant 2006;6:2060-2068.
26. Gmyr V, Belaich S, Muharram G, et al. Rapid purification of human ductal cells from human pancreatic fractions with surface antibody CA19-9. Biochem Biophys Res Commun 2004;320:27-33.
27. Cantaluppi V, Biancone L, Romanazzi GM, et al. Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: relevance for islet transplantation. Am J Transplant 2006;6:2601-2611.
28. Moberg L, Johansson H, Lukinius A, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002;360:2039-2045.
29. Johansson H, Lukinius A, Moberg L, et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005;54:1755-1762.
30. Gao R, Ustinov J, Korsgren O, et al. Effects of immunosuppressive drugs on in vitro neogenesis of human islets: mycophenolate mofetil inhibits the proliferation of ductal cells. Am J Transplant 2007;7:1021-1026.
31. Soria B, Roche E, Berna G, et al. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin induced diabetic mice. Diabetes 2000;49:157-162.
32. Lumelsky N, Blondel O, Laeng P, et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001;292:1389-1394.
33. Yang L, Li S, Hatch H, et al. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci USA 2002;99:8078-8083.
34. Kodama S, Kuhtreiber W, Fujimura S, et al. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 2003;302:1223-1227.
35. Ianus A, Holz GG, Theise ND, et al. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003;111:843-850.
36. Bouwens L, Pipeleers DG. Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia 1998;41:629-633.
37. van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000;67:2-17.
38. van Kooten C, Banchereau J. Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol 1997;9:330-337.
39. Klein D, Barbe-Tuana F, Pugliese A, et al. A functional CD40 receptor is expressed in pancreatic beta cells. Diabetologia 2005;48:268-276.
40. Barbe-Tuana FM, Klein D, Ichii H, et al. CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets. Diabetes 2006;55:2437-2445.
41. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998;16:111-135.
42. Fraker C, Timmins MR, Guarino RD, et al. The use of the BD oxygen biosensor system to assess isolated human islets of langerhans: oxygen consumption as a potential measure of islet potency. Cell Transplant 2006;15:745-758.
43. Papas KK, Colton CK, Nelson RA, et al. Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice. Am J Transplant 2007;7:707-713.
44. Wang W, Upshaw L, Strong DM, et al. Increased oxygen consumption rates in response to high glucose detected by a novel oxygen biosensor system in non-human primate and human islets. J Endocrinol 2005;185:445-455.
45. Goto M, Holgersson J, Kumagai-Braesch M, et al. The ADP/ATP ratio: a novel predictive assay for quality assessment of isolated pancreatic islets. Am J Transplant 2006;6:2483-2487.
46. Armann B, Hanson MS, Hatch E, et al. Quantification of basal and stimulated ROS levels as predictors of islet potency and function. Am J Transplant 2007;7:38-47.
47. Piemonti L, Leone BE, Nano R, et al. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 2002;51:55-65.
48. Bertuzzi F, Marzorati S, Maffi P, et al. Tissue factor and CCL2/monocyte chemoattractant protein-1 released by human islets affect islet engraftment in type 1 diabetic recipients. J Clin Endocrinol Metab 2004;89:5724-5728.